Observation and consideration on using of JAKi in clinical trials in times of COVID-19

Dermatol Ther. 2020 Nov;33(6):e13831. doi: 10.1111/dth.13831. Epub 2020 Jul 13.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alopecia Areata / drug therapy*
  • COVID-19*
  • Humans
  • Janus Kinase Inhibitors / administration & dosage*
  • Janus Kinase Inhibitors / adverse effects
  • Middle Aged

Substances

  • Janus Kinase Inhibitors